• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Panbela Therapeutics Shares Are Trading Higher By Around 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    4/12/23 12:47:37 PM ET
    $AAL
    $AGLE
    $ARWR
    $BACK
    Air Freight/Delivery Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAL alert in real time by email

    Gainers

    • TESSCO Technologies Incorporated (NASDAQ:TESS) shares jumped 86.8% to $8.78 as it agreed to be acquired by entities affiliated with Lee Equity Partners and Twin Point Capital for $9.00 in cash, resulting in an enterprise value of $161.4 million.
    • National CineMedia, Inc. (NASDAQ:NCMI) jumped 84% to $0.37. National CineMedia disclosed filing a voluntary Chapter 11 petition in the U.S. Bankruptcy Court for the Southern District of Texas.
    • Altamira Therapeutics Ltd. (NASDAQ:CYTO) gained 64.8% to $2.1759 after the company reported publication of results from Phase 2 trial with AM-125 in acute vestibular syndrome in leading peer reviewed journal.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) surged 52% to $1.3563. HeartCore forged an agreement with rYojbaba Inc for its tenth Go IPO consulting service win.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) rose 39% to $22.98.
    • Liquid Media Group Ltd. (NASDAQ:YVR) climbed 37.4% to $0.2050 after dropping 17% on Tuesday. Liquid Media Group recently announced it received an additional deficiency notice from Nasdaq.
    • Jowell Global Ltd. (NASDAQ:JWEL) surged 36.8% to $0.3693.
    • Triton International Limited (NYSE:TRTN) gained 32% to $83.20 after Brookfield Infrastructure announced it will acquire the company for consideration valued at $85 per share.
    • China Index Holdings Limited (NASDAQ:CIH) gained 31.1% to $0.9310 after gaining more than 7% on Tuesday.
    • Rosecliff Acquisition Corp I (NASDAQ:RCLF) shares climbed 28% to $13.43 after gaining 5% on Tuesday.
    • Hillstream BioPharma, Inc. (NASDAQ:HILS) rose 27% to $1.0712
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) gained 25.1% to $0.5416 after the company announced the first patient has been enrolled in the Phase II trial of CPP-1X-T.
    • X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) rose 16.8% to $1.11. X4 Pharmaceuticals said its late-breaker abstract entitled "Results of a Phase 3 trial of an oral CXCR4 antagonist, Mavorixafor, for whim syndrome" has been accepted for oral presentation at the Annual Meeting of the Clinical Immunology Society.
    • Freight Technologies, Inc. (NASDAQ:FRGT) jumped 14.8% to $2.48. Freight Technologies regained compliance with Nasdaq listing rule.
    • SiriusPoint Ltd. (NYSE:SPNT) gained 13.4% to $9.48. Daniel Loeb said it has full confidence in SiriusPoint's approach to de-risking of investment portfolio to strengthen balance sheet, capital position.
    • Stryve Foods, Inc. (NASDAQ:SNAX) rose 13.1% to $0.55. Stryve Foods’ meat snacks category brand, Vacadillos, expanded its presence with the rollout of its newest products.
    • Horizon Acquisition Corporation II (NASDAQ:HZON) climbed 12.2% to $11.28. Flexjet agreed to terminate business combination with Horizon Acquisition Corporation II.
    • Textainer Group Holdings Limited (NYSE:TGH) gained 11.7% to $35.92. Textainer Group said Q4 adjusted EPS and sales results were lower year over year.
    • Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) jumped 10.6% to $29.02. SVB Securities upgraded Arrowhead Pharma from Market Perform to Outperform and raised the price target from $21 to $35.
    • Chart Industries, Inc. (NYSE:GTLS) gained 10.5% to $124.29.
    • National Instruments Corporation (NASDAQ:NATI) climbed 9.5% to $57.58 after Emerson Electric Co (NYSE:EMR) agreed to acquire the company for $60 per share.
    • MongoDB, Inc. (NASDAQ:MDB) gained 7.3% to $227.02 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $230 to $270.

    Losers

    • Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) shares fell 35% to $0.1655 after the company announced interim results the ongoing Phase 1/2 clinical trial of pegtarviliase for the treatment of Classical Homocystinuria and said it is exploring strategic alternatives.
    • Cutera, Inc. (NASDAQ:CUTR) shares dropped 26.5% to $19.89 after the company announced the immediate terminations of Executive Chairman Daniel Plants and CEO David Mowry for cause and withdrew 2023 outlook.
    • iMedia Brands, Inc. (NASDAQ:IMBI) fell 22.5% to $0.4023 after reporting weaker-than-expected Q4 results.
    • Blue Safari Group Acquisition Corp. (NASDAQ:BSGA) declined 21.7% to $7.29. Blue Safari Group Acquisition and Bitdeer Technologies Group announced shareholder approval of business combination.
    • Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) dropped 21% to $0.6798.
    • NaaS Technology Inc. (NASDAQ:NAAS) fell 19.1% to $8.51.
    • MMTec, Inc. (NASDAQ:MTC) fell 18.5% to $0.9039.
    • 1847 Holdings LLC (NYSE:EFSH) dropped 18.3% to $0.4899.
    • ContextLogic Inc. (NASDAQ:WISH) declined 17.5% to $8.09. ContextLogic, on Tuesday, announced a 1-for-30 reverse stock split.
    • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) fell 17% to $0.0979. Virgin Orbit Holdings shares dropped around 30% on Tuesday after the company received a delisting notice.
    • Innovative Eyewear, Inc. (NASDAQ:LUCY) fell 15% to $3.70. Innovative Eyewear filed patent for ChatGPT enabled smart eyewear.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) dropped 14.4% to $1.7022. ZeroFox recently partnered with Google Cloud to disrupt phishing attacks and malicious URLs.
    • IMAC Holdings, Inc. (NASDAQ:BACK) fell 13.5% to $0.1620 after jumping 50% on Tuesday.
    • QualTek Services Inc. (NASDAQ:QTEK) dipped 12.8% to $0.3310.
    • Organigram Holdings Inc. (NASDAQ:OGI) fell 12.3% to $0.6002 after the company reported Q2 financial results.
    • Nutex Health Inc. (NASDAQ:NUTX) fell 12.1% to $0.8401. Nutex Health recently entered into a $100 million pre-paid advance agreement with Yorkville Advisors Global.
    • Cirrus Logic, Inc. (NASDAQ:CRUS) dipped 10.8% to $90.79.
    • Brenmiller Energy Ltd (NASDAQ:BNRG) shares dropped 10.7% to $2.0995. Brenmiller is in advanced discussions to collaborate with leading global clean energy company to decarbonize heat and energy production worldwide.
    • Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) fell 9.6% to $22.59 after the company announced preliminary Q1 financial results and a proposed convertible senior notes offering.
    • American Airlines Group Inc. (NASDAQ:AAL) dropped 8.1% to $13.15 after the company issued preliminary results below analyst expectations.

    Now Read This: Ethereum Falls Below This Key Level Following Inflation Data; Rocket Pool, Conflux Among Top Losers

    Get the next $AAL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAL
    $AGLE
    $ARWR
    $BACK

    CompanyDatePrice TargetRatingAnalyst
    Emerson Electric Company
    $EMR
    3/31/2026$175.00Buy
    Jefferies
    Emerson Electric Company
    $EMR
    3/27/2026$150.00Market Perform
    BMO Capital Markets
    MongoDB Inc.
    $MDB
    3/23/2026$325.00Neutral → Outperform
    Mizuho
    X4 Pharmaceuticals Inc.
    $XFOR
    3/9/2026$12.00Buy
    Guggenheim
    American Airlines Group Inc.
    $AAL
    3/5/2026$12.50Buy → Neutral
    Rothschild & Co Redburn
    MongoDB Inc.
    $MDB
    3/5/2026$310.00Sector Perform → Sector Outperform
    Scotiabank
    MongoDB Inc.
    $MDB
    3/3/2026$260.00Outperform → Neutral
    Robert W. Baird
    MongoDB Inc.
    $MDB
    3/3/2026$400.00 → $340.00Outperform
    BMO Capital Markets
    More analyst ratings

    $AAL
    $AGLE
    $ARWR
    $BACK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer-Healthcare Montgomery Pamela W. bought $7,021 worth of shares (79 units at $88.87), increasing direct ownership by 3% to 2,758 units (SEC Form 4)

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/16/26 3:02:43 PM ET
    $NUTX
    Real Estate

    Director Heron Patrick J acquired 159,277 shares and bought $8,999,984 worth of shares (131,425 units at $68.48) (SEC Form 4)

    4 - Mirum Pharmaceuticals, Inc. (0001759425) (Issuer)

    1/27/26 4:14:26 PM ET
    $MIRM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Gross Harrison R. bought $1,980 worth of shares (1,500 units at $1.32), increasing direct ownership by 12% to 13,733 units (SEC Form 4)

    4 - Innovative Eyewear Inc (0001808377) (Issuer)

    1/22/26 11:29:05 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $AAL
    $AGLE
    $ARWR
    $BACK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 21, 2025 - FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease

    For Immediate Release: February 21, 2025 Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, a very rare lipid storage disease.“The FDA is dedicated to supporting new drug development for rare diseases including very rare metabolic diseases like cerebrotendinous xanthomato

    2/21/25 11:48:20 AM ET
    $MIRM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XOLREMDI issued to X4 PHARMACEUTICALS INC

    Submission status for X4 PHARMACEUTICALS INC's drug XOLREMDI (ORIG-1) with active ingredient MAVORIXAFOR has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218709, Application Classification: Type 1 - New Molecular Entity

    4/29/24 2:36:51 PM ET
    $XFOR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAL
    $AGLE
    $ARWR
    $BACK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HeartCore Announces 1-for-20 Reverse Stock Split

    NEW YORK and TOKYO, April 01, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (NASDAQ:HTCR) ("HeartCore" or the "Company"), an IPO consulting services company based in Tokyo, today announced that its Board of Directors approved a 1-for-20 reverse stock split of its issued and outstanding common stock (the "Reverse Split"). As previously announced, on June 30, 2025, HeartCore stockholders approved the Reverse Split and granted the Board of Directors the authority to determine the exact split ratio (within the range approved by stockholders) and when to proceed with the Reverse Split. The Reverse Split will become effective on April 2, 2026 at 4:00 p.m. Eastern Time ("Effective Time")

    4/1/26 8:05:00 AM ET
    $HTCR
    EDP Services
    Technology

    HeartCore Reports Full Year 2025 Results

    NEW YORK and TOKYO, March 31, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (NASDAQ:HTCR) ("HeartCore" or the "Company"), an IPO consulting services company based in Tokyo, reported financial results for the full year ended December 31, 2025. Recent Operational Highlights As of March 31, 2026, HeartCore was engaged with 16 Go IPO clients, including 6 clients currently in various stages of preparation for potential public registrations and U.S. exchange listings.Authorized one-time distribution payment to stockholders.Authorized $2.0 million share repurchase program.Divested software business subsidiary, HeartCore Co., Ltd ("HeartCore Japan").Established Higgs Field Co., Ltd. ("Hig

    3/31/26 4:30:00 PM ET
    $HTCR
    EDP Services
    Technology

    LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year

    BOCA RATON, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (NASDAQ:LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has filed its Annual Report on Form 10-K for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The report is available on the Company's website, www.lixte.com, and on the SEC's website, www.sec.gov. "2025 was a transformative and highly productive year for our Company," said Geordan Pursglove, who was named LIXTE's Chairman and Chief Executive Officer in June 2025. "We strengthened LIXTE's foundation by assembling an

    3/31/26 3:45:00 PM ET
    $LIXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAL
    $AGLE
    $ARWR
    $BACK
    SEC Filings

    View All

    Heartcore Enterprises Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - HeartCore Enterprises, Inc. (0001892322) (Filer)

    4/1/26 8:05:07 AM ET
    $HTCR
    EDP Services
    Technology

    SEC Form 15-12G filed by IMAC Holdings Inc.

    15-12G - IMAC Holdings, Inc. (0001729944) (Filer)

    3/31/26 4:44:14 PM ET
    $BACK
    Medical Specialities
    Health Care

    SEC Form 10-K filed by Heartcore Enterprises Inc.

    10-K - HeartCore Enterprises, Inc. (0001892322) (Filer)

    3/31/26 4:35:53 PM ET
    $HTCR
    EDP Services
    Technology

    $AAL
    $AGLE
    $ARWR
    $BACK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Wang Yang

    3 - NaaS Technology Inc. (0001712178) (Issuer)

    4/1/26 9:07:53 AM ET
    $NAAS
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 3 filed by new insider Sun Weilin

    3 - NaaS Technology Inc. (0001712178) (Issuer)

    4/1/26 9:07:11 AM ET
    $NAAS
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 3 filed by new insider Ren Xiaofei

    3 - MMTEC, INC. (0001742518) (Issuer)

    3/31/26 12:42:52 PM ET
    $MTC
    Computer Software: Prepackaged Software
    Technology

    $AAL
    $AGLE
    $ARWR
    $BACK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jefferies resumed coverage on Emerson with a new price target

    Jefferies resumed coverage of Emerson with a rating of Buy and set a new price target of $175.00

    3/31/26 8:12:03 AM ET
    $EMR
    Consumer Electronics/Appliances
    Technology

    BMO Capital Markets initiated coverage on Emerson with a new price target

    BMO Capital Markets initiated coverage of Emerson with a rating of Market Perform and set a new price target of $150.00

    3/27/26 8:48:14 AM ET
    $EMR
    Consumer Electronics/Appliances
    Technology

    MongoDB upgraded by Mizuho with a new price target

    Mizuho upgraded MongoDB from Neutral to Outperform and set a new price target of $325.00

    3/23/26 8:23:30 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    $AAL
    $AGLE
    $ARWR
    $BACK
    Leadership Updates

    Live Leadership Updates

    View All

    Innovative Eyewear, Inc. Announces New Smart Safety Glasses and Rx Safety Partner

    MIAMI, March 31, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer & manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands, is pleased to announce the launch of the new Lucyd Armor® Vantage style. The new smart safety frame is fully certified for workplace use under US, Canadian and European standards. The frame will debut on March 31, 2026 at the National Hardware Show: Concept to Commerce event in Las Vegas. The frame will launch on the Company's website as well as with its new premier reseller for the safety channel, Ocusafe.com.

    3/31/26 8:00:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting

    Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), is pleased to announce that the shareholders of Organigram have overwhelmingly approved the resolution required to consummate the previously announced acquisition by the Company (the "Transaction") of Sanity Group GmbH ("Sanity Group") and the related private placement financing (the "Private Placement") with BT DE Investments Inc., a wholly-owned subsidiary of British American Tobacco ("BAT") at the Company's annual general and special meeting of shareholders (the "Shareholders") held on March 30, 2026 (the "Meeting"). Shareholders approved an ordinary resolution (the "Transaction Resolution") authorizing (i)

    3/30/26 8:30:00 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MongoDB Appoints Ryan Mac Ban as Chief Revenue Officer to Support Next Phase of Growth

    NEW YORK, March 24, 2026 /PRNewswire/ -- MongoDB (NASDAQ:MDB) today announced the appointment of Ryan Mac Ban as Chief Revenue Officer (CRO), effective April 27, 2026. Reporting to President and Chief Executive Officer (CEO) CJ Desai, Mac Ban will lead MongoDB's global sales team. Following the recent appointment of Erica Volini as Chief Customer Officer, Mac Ban's arrival further strengthens MongoDB's go-to-market leadership team as the company enters its next phase of growth. "This is an important moment for MongoDB. Ryan brings deep experience leading global organizations thr

    3/24/26 8:50:00 AM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    $AAL
    $AGLE
    $ARWR
    $BACK
    Financials

    Live finance-specific insights

    View All

    HeartCore Reports Full Year 2025 Results

    NEW YORK and TOKYO, March 31, 2026 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (NASDAQ:HTCR) ("HeartCore" or the "Company"), an IPO consulting services company based in Tokyo, reported financial results for the full year ended December 31, 2025. Recent Operational Highlights As of March 31, 2026, HeartCore was engaged with 16 Go IPO clients, including 6 clients currently in various stages of preparation for potential public registrations and U.S. exchange listings.Authorized one-time distribution payment to stockholders.Authorized $2.0 million share repurchase program.Divested software business subsidiary, HeartCore Co., Ltd ("HeartCore Japan").Established Higgs Field Co., Ltd. ("Hig

    3/31/26 4:30:00 PM ET
    $HTCR
    EDP Services
    Technology

    LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year

    BOCA RATON, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (NASDAQ:LIXT), a clinical stage pharmaceutical and med-tech company focused on advancing cancer treatments, today announced it has filed its Annual Report on Form 10-K for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission. The report is available on the Company's website, www.lixte.com, and on the SEC's website, www.sec.gov. "2025 was a transformative and highly productive year for our Company," said Geordan Pursglove, who was named LIXTE's Chairman and Chief Executive Officer in June 2025. "We strengthened LIXTE's foundation by assembling an

    3/31/26 3:45:00 PM ET
    $LIXT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Innovative Eyewear Inc. Reports Full Year 2025 Financial Results

    Revenue increased 63% over prior year Gross Profit Margins increased by 8 percentage points despite tariff headwindsMIAMI, March 25, 2026 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW)), the developer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands, today announced its full year 2025 financial results. Net revenue for the year ended December 31, 2025 was approximately $2.67 million, an increase of $1.03 million or 63% from the year ended December 31, 2024. This strong year-over-year revenue growth was primarily driven by

    3/25/26 4:30:00 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    $AAL
    $AGLE
    $ARWR
    $BACK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Brenmiller Energy Ltd

    SC 13D/A - Brenmiller Energy Ltd. (0001901215) (Subject)

    12/5/24 11:18:20 AM ET
    $BNRG
    Building Products
    Industrials

    Amendment: SEC Form SC 13D/A filed by SiriusPoint Ltd.

    SC 13D/A - SiriusPoint Ltd (0001576018) (Subject)

    11/26/24 4:41:55 PM ET
    $SPNT
    Property-Casualty Insurers
    Finance